5,045
edits
Glycoprotein IIb/IIIa inhibitors: Difference between revisions
Created page with "'''Glycoprotein IIb/IIIa inhibitors''' are antiplatelets. They are mostly used for short-term treatment before and during percutaneous coronary intervention. They are administered by i.v. injection, == Compounds == * Abciximab * Eptifibatide * Tirofiban == Mechanism of action == These drugs bind to and inhibit the receptors glycoprotein IIb/IIIa, which prevents platelets from binding to each other and therefore preventing aggregation.<noinclude>Category:Pharmaco..."
(Created page with "'''Glycoprotein IIb/IIIa inhibitors''' are antiplatelets. They are mostly used for short-term treatment before and during percutaneous coronary intervention. They are administered by i.v. injection, == Compounds == * Abciximab * Eptifibatide * Tirofiban == Mechanism of action == These drugs bind to and inhibit the receptors glycoprotein IIb/IIIa, which prevents platelets from binding to each other and therefore preventing aggregation.<noinclude>Category:Pharmaco...") |
(No difference)
|